Natural killer (NK) cells can attack cells infected with certain pathogens [1, 2] and kill transformed cells [3] . Moreover, NK cells regulate adaptive immune responses [4] . Of clinical relevance is their ability to mediate in part the therapeutic activity of antibodies against tumors [5] . Finally, NK cells can influence the outcome of bone marrow transplantation. Recipient NK cells can completely prevent engraftment [6] , whereas alloreactive donor NK cells can prevent graft versus host reactions [7] and may exert graft versus leukemia effects [7] . For a long time considered as being non-specific, the understanding of the molecular basis for the NK cell's discriminatory capacities has made considerable progress. We will distinguish three distinct recognition strategies used by NK cells to identify diseased or distressed host cells. These different recognition strategies do not act separately but are rather used in a cooperative fashion.
Recognition of ''non-self'' ligands
Natural killer cells detect pathogen-infected host cells by directly recognizing pathogen-encoded molecules. For instance, NK cells from certain mouse strains protect from lethal MCMV (Mouse Cytomegalovirus) infection. NK cells recognize the MCMV-encoded protein m157 on the surface of infected cells [8, 9] . The recognition of this foreign protein is mediated by the Ly49H receptor [10] . Interestingly, the NK-cell response selects MCMV variants with mutant m157, which escape Ly49H recognition. If the early MCMV infection is counteracted by NK cells, mutant viruses are subsequently controlled by an adaptive immune response [11] . These findings highlight the importance and the efficacy of NK cells during early MCMV infection. The human NKp46 and NKp44 NK-cell activation receptors may also be involved in pathogen recognition, as they were shown to bind influenza virus haemagglutinin [12] .
In addition to recognizing pathogen-infected host cells, NK cells may have the capacity to directly recognize and respond to pathogen components through Tolllike receptors (TLRs) [13, 14] .
Recognition of constitutively expressed ''self'' ligands
Besides the direct recognition of foreign protein or pathogen components, NK cells are equipped to determine whether various endogenous self-proteins are normally expressed. To this end, NK cells use a dual receptor system. They express a whole array of receptors that transmit activation signals upon interacting with a potential target cell [15] . In this context, we use the term ''activation'' to indicate the triggering of NK-cell effector functions such as cytolysis or the production of cytokines. In general, activation receptors are specific for incompletely defined, but constitutively expressed ligands on potential target cells. Under normal circumstances, NK-cell activation is counteracted by inhibitory NK-cell receptors, which interact with MHC-I (major histocompatibility complex class I) molecules on target cells. A significant number of inhibitory NK-cell receptors, which are specific for non-MHC-I ligands, have also been identified [16] [17] [18] [19] . The importance of these receptors and how the signals from non-MHC and MHC-I-specific inhibitory receptors are integrated are currently unclear.
Natural killer cell inhibition by MHC-I on target cells enables NK cells to kill MHC-I loss variants. In this case, NK cells fail to receive inhibitory signals such that NK-cell activation can proceed unopposed. This type of recognition has been termed ''missing-self'' recognition [20] . Total or selective MHC-I loss or down-modulation is a frequent event during viral infections or transformation [21, 22] . It is thus thought that the recognition of MHC-I loss by NK cells complements T-cell-mediated immunity.
A special case of missing-self reactivity may be the lysis of immature dendritic cells (DC). NK-cell activation upon the interaction with DC occurs mainly via human NKp30. Mature DC are protected from lysis since they express high levels of HLA-E, which inhibits NK cells via the CD94/NKG2A receptor. In contrast, HLA-E expression on immature DC is low, allowing NK-cell-mediated lysis [23] . The interaction with DC likely reflects an immunoregulatory function of NK cells, which influences subsequent adaptive immune responses [24] .
Recognition of ''induced-self'' ligands
In addition to activation receptors, which recognize constitutively expressed ligands, NK cells also express receptors, which are specific for ligands that can be induced on host cells but that are not normally expressed. The NKG2D receptor serves as a paradigm for this type of recognition (for review see [25] ). Ligands for NKG2D, which include RAE, MULT1 and H60 proteins in the mouse and MICA/B and RAET in humans, are not normally expressed on host cells. Importantly, such ligands can be induced upon various cellular insults including stress [26] , infection [27, 28] and transformation [29] . However, NKG2D ligands can also be induced during the course of normal cellular activation and differentiation [30] . Irrespectively, upon the interaction with host cells expressing NKG2D ligand, NK cells receive additional activation signals. In this case, host cells can be lysed even though they express MHC-I molecules normally, thus the term ''induced-self'' recognition [31] . Interestingly, the majority of the transformed cell lines commonly used in vitro constitutively express NKG2D ligands. An important area for future research will thus be to determine how these genes are regulated.
Besides NKG2D ligands, it has been noted before that CD80 (B7-1) expression by target cells can override NK-cell inhibition [32] . Moreover, antibody-dependent cell mediated cytotoxicity (ADCC) can be considered to belong to the same recognition category. NK cells can recognize and kill antibody-coated target cells, using FccRIII (CD16). Similar to NKG2D, ADCC can override NK-cell inhibition and allow the lysis of MHC-I-expressing target cells [33] .
Thus, over the last years, NK-cell activation has emerged as a complex and regulated process, which involves a significant number of distinct NK-cell receptors. Even though complete knowledge of all the relevant ligands is still lacking, it has become apparent that certain activation receptors recognize inducible ligands. Moreover, there are activating NK-cell receptors, such as human NKp44, that are themselves inducible via the action of cytokines [34] .
In contrast to this, our view of NK-cell inhibition has remained relatively simple. NK-cell inhibition depended on the presence of the MHC-I ligand on the target cell and the presence of a specific inhibitory receptor on NK cells. We have recently made observations, which challenge this simplistic view. In order to discuss these findings and their implications, we will first introduce the experimental system we established over the past years.
Inhibitory MHC-I receptors
The prototype inhibitory receptor for classical MHC-I in mouse is Ly49A, a homodimeric C-type lectin-like receptor. Ly49A is part of a multigene family with >20 members [35, 36] , whereby different mouse strains have variable numbers of Ly49 genes and individual receptors are polymorphic [37] . Ly49 receptors are tightly linked in the so-called NK gene complex (NKC) on mouse chromosome 6 [38] .
Both inhibitory and activating Ly49 family members have been found. The function of the latter is still somewhat enigmatic, even though one activating Ly49, Ly49H, recognizes MCMV m157, as discussed above. The majority of the inhibitory receptors are specific for classical MHC-I [39] . Importantly, Ly49 receptors may be selective for certain MHC-I isotypes and may even discriminate certain alleles of MHC-I molecules. For instance, Ly49A inhibits mouse NK cells upon interaction with H- [40] .
The Ly49A receptor is expressed by approximately 20% of NK cells, irrespective of whether a particular mouse strain expresses a corresponding MHC-I ligand. This suggests that Ly49 receptor expression is not directed by MHC-I. Ly49 receptors are differentially expressed such that individual NK cells express a selection of the available receptors. Thus, using a relatively small number of receptors, NK cells generate a relatively complex receptor repertoire.
So far, functional Ly49 proteins have not been found in humans. Rather, human NK cells use a structurally distinct family of Ig-like receptors, the so-called killer inhibitory receptors (KIR) to recognize classical MHC-I molecules [41] . Despite the structural differences, KIR and Ly49 receptors mediate identical functions, are similarly selective for some but not all MHC-I molecules and are clonally distributed in a comparable fashion.
Cross-linking of inhibitory MHC-I receptors results in the phosphorylation of a tyrosine residue, which is central to the so-called ITIM (for immuno receptor tyrosine-based inhibition motif: I/S/T/LxYxxL/V), located in the cytoplasmic tail of the receptor. ITIM phosphorylation results in the recruitment and activation of phosphatases including SHP-1 and SHP-2 [42] . In turn, phosphatase activity interrupts the action of NK-cell activation pathways by dephosphorylating essential signaling intermediates, such as Vav1 [43] .
Ly49A transgenic mice
In order to somewhat simplify the complex NK-cell receptor repertoire, we generated Ly49A transgenic (Tg) mice [44] . In these mice, all NK cells have at least one inhibitory receptor in common. However, endogenous Ly49 receptors are still expressed [45] . The transgenic Ly49A conferred D d -specific NK-cell inhibition and prevented T-cell responses to allogeneic stimulator cells when these expressed inhibitory MHC-I ligand. This has provided formal evidence that Ly49A is an inhibitory receptor and not just a co-receptor for another, unknown receptor.
NK-cell inhibition is regulated by the MHC-I of the NK cells
Unexpectedly, the capacity of Ly49A to inhibit NK cells depends on the MHC-I background [46] . The crystal structure of Ly49A-D d complexes suggested the existence of two distinct sites of interaction between Ly49A and D d [50] . On the one hand, Ly49A interacted with amino and carboxy terminal residues of the a1 and a2 helix, respectively (site 1). A second site was located laterally, beneath the floor of the peptide-binding groove, making contacts with residues of the a2, a3 and b 2 m domains (site 2). Interestingly, site 2 is similar to the binding site used by CD8 [51] . Subsequent site-directed mutagenesis analysis demonstrated that site 2 was the binding site used for Ly49A trans interaction, which mediates NK-cell inhibition [52, 53] .
It was thus important to determine whether the binding site used for cis association was site 1 or site 2 or even an unknown third binding site. The analysis of a series of point mutations in D d as well as the use of species-specific differences in b 2 m revealed that cis and trans interactions use the same binding sites, i.e. site 2 [46] . Thus, cis and trans interactions show exactly the same specificity.
Since binding site 2 is not symmetric, it is not immediately obvious how Ly49A can recognize D d in trans or cis using a single binding site. Moreover, a Ly49A homodimer interacts with a single D d molecule [50] , suggesting that simultaneous binding in cis and trans is excluded. However, there is no structural information available regarding the Ly49A stalk (the connector between the plasma membrane and the carbohydrate recognition domain (CRD), which mediates MHC-I binding). We thus hypothesize that Ly49A adopts an extended conformation to recognize D d in trans, whereas a back-folded conformation would be required to interact with D d in cis. The above model implies that considerable flexibility of the Ly49A stalk is required to enable both cis and trans interactions by Ly49A. This model has some resemblance to the distinct conformational states adopted by active and resting integrins [54] .
Implications for NK-cell function
Why should most of the Ly49A receptors be bound to D d in cis and thus be unavailable to inhibit NK-cell function upon the interaction with a D d -expressing target cell? First, it is important to note that our functional evidence suggests that Ly49A, which is bound in cis, does not constitutively transmit inhibitory signals [46] . Thus, only the Ly49A receptors, which are available for trans interaction, seem to participate in NK-cell inhibition upon target cell interaction. Second, the small amount of accessible Ly49A on D d -expressing NK cells is apparently sufficient to inhibit NK cells in response to normal, D d -expressing target cells [55] and thus sufficient to ensure self-tolerance. Since the number of accessible Ly49A molecules is small, a relatively minor reduction in D d expression on target cells will be sufficient to abrogate NK-cell inhibition. Alternatively, minor increases in NK-cell activation, e.g. upon the expression of NKG2D ligands on target cells, are sufficient to overcome NK-cell inhibition [46] .
Concluding remarks
Natural killer cell function is negatively regulated by inhibitory receptors interacting with MHC-I molecules expressed on target cells. We have found that the inhibitory Ly49A NK-cell receptor not only binds to its D d ligand expressed on potential target cells (i.e. in trans), but is constitutively associated with D d in cis (i.e. on the same cell). Cis association seems to limit the number of Ly49A receptors available for binding D d on target cells. In this way, cis association limits NK-cell inhibition via Ly49A. Consequently, cis association lowers the threshold at which NK-cell activation exceeds NK-cell inhibition. This allows an optimal discrimination of healthy from distressed or diseased host cells. Thus, the NK cell's own MHC-I plays an important role in the regulation of the function of murine NK cells.
